Migraine Headache
Conditions
Keywords
Mesotherapy, Migraine
Brief summary
Introduction:Migraine is a prevalent disabling primary headache disorder which is classified in two major types; migraine without aura and migraine with aura. The aim of this study was to compare the efficiency of mesotherapy with systemic therapy in pain controlin patients with headache related tomigraine without aura. Methods: We conducted this prospective parallel randomized controlled trial with the patients admitted to the emergency department with headache related to migraine without aura. One group was treated with mesotherapy, and the control group with intravenous dexketoprofen. Changes in pain intensity at 30th minute, 60th minute, 120th minute and 24th hours after treatment using Visual Analogue Scale (VAS), need to use analgesic drug within 24 hours,re-admission with same complaint to emergency department (ED) within 72 hours, and adverse effect rate of the methods were compared between groups.
Interventions
Mesotherapy was performed by an experienced and trained physician using disposable 4 mm and 6 mm long 30 Gauge needles (Meso-relle, Biotekne SRL, Italy)to the pericarotid region, glabella, and the area between the eyes and ears, and to the area of the head where pain occurred (such as frontal, parietal, occipital region) for each patient
Sponsors
Ataturk University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18 years and older age, and (2) * Admission to Emergency Department (ED) with headache related to the migraine without aura.
Exclusion criteria
* Taking analgesic drugs before admission, * Having VAS score of lower than 4 on admission, * Having diabetes mellitus, * Body mass index\>30 kg/m2, * Pregnancy, * Lactation, * Having active bleeding or bleeding disorder, * Having active or recurrent gastrointestinal hemorrhage or ulcer, or history of these conditions, * Having a serious or life-threatening condition (stroke, intracranial hemorrhage, heart attack, cardiac tamponade, pneumothorax, hemothorax, flail chest, etc.).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| change in headache intensity | 0-24 hours | Visual Analog Score(points between 0-10. the most severe pain 10 points, no pain 0 points) scores at 30th, 60th and 120th minutes, and 24th hours from the baseline VAS score (at the beginning of the treatment). |
| need to use analgesics within 24 hours after treatment | 0-24 hours | We defined this as a requirement of any type analgesics for painkilling at any time within 24 hours of treatment, and this was evaluated by patients, subjectively. we will learn by asking by phone. |
Countries
Turkey (Türkiye)
Outcome results
None listed